Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Effectiviteit en veiligheid van 104 weken subcutaan lenacapavir bij multiresistente hiv-1
jul 2025 | HIV, Virale infecties